RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC after failure of platinum-based chemotherapy in Brazil - RACE-2L

Study identifier:D133HR00041

ClinicalTrials.gov identifier:NCT06491862

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous Non-Small Cell Lung Cancer after failure of platinum-based chemotherapy in Brazil

Medical condition

Non-squamous Non-Small Cell Lung Cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

250

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 25 Jul 2024
Estimated Primary Completion Date: 31 Mar 2025
Estimated Study Completion Date: 31 Mar 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria